Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
|Slideshows|February 28, 2020
- Vol 37, Issue 2
- Volume 37
- Issue 2
In This Issue of Psychiatric Times: Vol 37, No 2
Author(s)Laurie Martin
Read the Psychiatric Times February 2020 issue cover-to-cover, with a bonus PDF.
Advertisement
Articles in this issue
over 6 years ago
Chaos Theory With a Human Face: Niall McLaren, MBBS, FRANZCPover 6 years ago
Introduction: Trauma and Its Psychiatric Consequencesover 6 years ago
Stroke in Young Adults: The Lasting Effects of Traumaover 6 years ago
The Show Must Go Onover 6 years ago
Psychiatric Malpractice Grand Rounds: Addiction Psychiatryover 6 years ago
The Arms of Ivy Welcome Herover 6 years ago
Bipolar Disorder: Practice-Changing Trials from 2019Advertisement
Related to this article
Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.
Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.
A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
2
Choosing an Antidepressant: Art, Science, and Knowing Your Patient
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
Responding to Intimate Partner Violence Disclosures in Psychiatry
5